Renal Impairment: No dosage adjustment is recommended for patients with mild, moderate, or severe renal impairment
THURSDAY, March 12, 2026 (HealthDay News) -- Formulation- and sex-specific associations are seen for semaglutide use with ischemic optic neuropathy, with increased odds in men and with Wegovy use, according to a study published online March 10 in the British Journal of Ophthalmology.Noting that ION has recently been linked to glucagon-like peptide-1 receptor agonist use, particularly semaglutide, Moiz Lakhani, from the University of Ottawa, and colleagues examined formulation- and sex-specific associations using more than 20 million reports from the U.S
Each goal should reflect personal needs, like losing a specific amount of weight, lowering A1C levels, or simply gaining better control over appetite and energy
Patients who have access to an FDA-approved product at the dose they need should use it